• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Previous Issues
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Parasitologists United Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2025)
Volume Volume 17 (2024)
Volume Volume 16 (2023)
Volume Volume 15 (2022)
Volume Volume 14 (2021)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 13 (2020)
Volume Volume 12 (2019)
Volume Volume 11 (2018)
Volume Volume 10 (2017)
Abaza, S. (2021). Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance. Parasitologists United Journal, 14(3), 244-260. doi: 10.21608/puj.2021.103436.1141
Sherif Abaza. "Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance". Parasitologists United Journal, 14, 3, 2021, 244-260. doi: 10.21608/puj.2021.103436.1141
Abaza, S. (2021). 'Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance', Parasitologists United Journal, 14(3), pp. 244-260. doi: 10.21608/puj.2021.103436.1141
Abaza, S. Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance. Parasitologists United Journal, 2021; 14(3): 244-260. doi: 10.21608/puj.2021.103436.1141

Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance

Article 3, Volume 14, Issue 3, December 2021, Page 244-260  XML PDF (562.93 K)
Document Type: Review Article
DOI: 10.21608/puj.2021.103436.1141
View on SCiNiTO View on SCiNiTO
Author
Sherif Abaza email
Medical Parasitology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
Abstract
Important obstacles facing programs involved in eradication of tropical diseases are drug resistance and environmental aspects surrounding the infected population including poverty, inefficient healthy sewage system, and popular habits. Treatment failure is determined by either persistence of clinical manifestations after scheduled drug regimen, or occurrence of disease relapse or new infections. This means that treatment failure in clinical studies does not mean drug resistance because identified parasite’ resistance to a certain drug does not include pharmacokinetics and pharmacogenetics studies as well as host immunological assessment. Coinfections, drug-drug interactions, and environmental factors also contribute in development of drug resistance. Of note, parasite gene mutation is the main mechanism suggested for drug resistance. The present work aims to review commonly reported drugs associated with resistance, and the proposed genetic markers of resistance
Keywords
drug resistance; gene mutation; genome plasticity, mechanism of resistance; mode of action; pharmacogenetics, pharmacokinetics
Statistics
Article View: 726
PDF Download: 1,049
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.